Kongressthemen Recent advances in injectable biologics and smart medical devices as led to an increase in novel approaches to treating severe asthma and COPD as well as the regulations to take into consideration. As technology soars, the need for guideline updates from regulators has increased and continues to be modified.
Kongressorganizer (PCO) SMi Group
Anmerkungen Speakers: Allergy Therapeutics, Amgen, AstraZeneca, Boehringer Ingelheim, Cambridge Consultants Ltd, GSK, Imperial College London, Janssen, Kings College London, MedImmune, MHRA, National Heart And Lung Institute, National University Health System
Kongressgebühr GBP 1.099,00 (Book by 15th December and save £400: GBP 1099,
Book by 31st January and save £200: GBP 1299,
Book by 28th February and save £100: GBP 1399,
Standard: GBP 1499)
Veranstalter Kontakt 83 Great Titchfield Street W1W 6RH London Großbritannien
